Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment.
Prolonged and symptomatic bradycardia following a single dose of fingolimod.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
Vitamin D and multiple sclerosis.
Self-rating makes the difference: Identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation.
Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints.
Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases.
Evaluation of clinical interest of anti-aquaporin-4 autoantibody followup in neuromyelitis optica.
Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging.
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
Preventive and Therapeutic Effects of Adenanthin on Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling.
Effects of propentofylline on CNS remyelination in the rat brainstem.
Acid Sphingomyelinase-Derived Ceramide Regulates ICAM-1 Function during T Cell Transmigration across Brain Endothelial Cells.
Highlights from the 31st ECTRIMS congress - Barcelona 2015.
Month of birth, vitamin D and risk of immune mediated disease: a case control study.
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica.
Sex ratio of infectious mononucleosis and possible relevance to multiple sclerosis.
Is It Too Early to Predict the Failure of Natalizumab in NMO?
Therapeutics to Promote CNS Repair: A Natural Human Neuron-Binding IgM Regulates Membrane-Raft Dynamics and Improves Motility in a Mouse Model of Multiple Sclerosis.
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease.
Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors b20-4.1.1 and angiostatin (k1-3).
Pages
« first
‹ previous
…
343
344
345
346
347
348
349
350
351
…
next ›
last »